NASDAQ | ETF
The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund"s investment sub-adviser, under the supervision of the adviser.
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| RDNT | RadNet Inc | Healthcare | Diagnostics & Research | 8.46% |
| WVE | Wave Life Sciences Ltd | Healthcare | Biotechnology | 6.34% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 6.23% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 6.13% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 5.86% |
| LIVN | LivaNova PLC | Healthcare | Medical Devices | 5.62% |
| MMSI | Merit Medical Systems Inc | Healthcare | Medical Instruments & Supplies | 5.00% |
| NEO | NeoGenomics Inc | Healthcare | Diagnostics & Research | 4.82% |
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 4.41% |
| COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.39% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 4.33% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 4.13% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 3.70% |
| RARE | Ultragenyx | Healthcare | Biotechnology | 3.66% |
| AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 2.72% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 2.67% |
| ATEC | Alphatec Holdings Inc | Healthcare | Medical Devices | 2.28% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 2.18% |
| TMDX | TransMedics Group Inc | Healthcare | Medical Devices | 1.77% |
| TBIL | Rbb Fund Inc - Us Treasury 3 Month Bill ETF | 1.63% |